Back
Black Diamond Therapeutics Quote, Financials, Valuation and Earnings
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
47
BDTX
Black Diamond Therapeutics
Last Price:
5.84
Seasonality Move:
25.38%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right hereBlack Diamond Therapeutics Price Quote
$5.84
-0.10 (-1.68%)
(Updated: May 14, 2024 at 10:30 AM ET)
Black Diamond Therapeutics Key Stats
Sell
47
Black Diamond Therapeutics (BDTX)
is a Sell
Day range:
$5.88 - $6.29
52-week range:
$1.57 - $7.66
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.2%
Volume:
424.2K
Avg. volume:
665.1K
1-year change:
214.29%
Market cap:
$334.1M
Revenue:
$0
EPS:
$-1.66
How Much Does Black Diamond Therapeutics Make?
Data Unavailable
Is Black Diamond Therapeutics Growing As A Company?
Data Unavailable
Black Diamond Therapeutics Stock Price Performance
-
Did Black Diamond Therapeutics Stock Go Up Last Month?
Black Diamond Therapeutics share price went up by 13.36% last month -
Did BDTX's Share Price Rise Over The Last Year?
BDTX share price rose by 214.29% over the past 1 year
What Is Black Diamond Therapeutics 52-Week High & Low?
-
What Is Black Diamond Therapeutics’s 52-Week High Share Price?
Black Diamond Therapeutics has traded as high as $7.66 over the past 52 weeks -
What Is Black Diamond Therapeutics’s 52-Week Low Share Price?
Black Diamond Therapeutics has traded as low as $1.57 over the past 52 weeks
Black Diamond Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Black Diamond Therapeutics?
-
How Much Debt Does Black Diamond Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Black Diamond Therapeutics Have?
Cash and short term investments quarterly total is $115.2M -
What Is Black Diamond Therapeutics’s Book Value Per Share?
Book value per share is 1.99
Is Black Diamond Therapeutics Cash Flow Positive?
-
What Is BDTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$67.9M -
What Is Black Diamond Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $76M -
What Is Black Diamond Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$22.2M
Black Diamond Therapeutics Return On Invested Capital
Data Unavailable
Black Diamond Therapeutics Earnings Date & Stock Price
-
What Is Black Diamond Therapeutics's Stock Price Today?
A single share of BDTX can be purchased today for 5.94 -
What Is Black Diamond Therapeutics’s Stock Symbol?
Black Diamond Therapeutics trades on the nasdaq under the ticker symbol: BDTX -
When Is Black Diamond Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Black Diamond Therapeutics is scheduled on August 9, 2024 -
When Is BDTX's next ex-dividend date?
Black Diamond Therapeutics's next ex-dividend date is May 14, 2024 -
How To Buy Black Diamond Therapeutics Stock?
You can buy Black Diamond Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Black Diamond Therapeutics Competitors
-
Who Are Black Diamond Therapeutics's Competitors?
Below is a list of companies who compete with Black Diamond Therapeutics or are related in some way:
Black Diamond Therapeutics Dividend Yield
Data Unavailable
Black Diamond Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 18.22% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 12.80 |
| Upside from Last Price: | 115.49% |